Req. No. 698 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 60th Legislature (2025)
SENATE BILL 993 By: Gollihare
AS INTRODUCED
An Act relating to pharmacy benefit managers;
amending 59 O.S. 2021, Sections 356.1, 356.2, 356.3,
as amended by Sections 1, 2, and 3, Chapter 332,
O.S.L. 2024, and 356.4 (59 O.S. Supp. 2024, Sections
356.1, 356.2, and 356.3), which relate to
definitions, pharmacy audit requirements, appeals
process, and prohibited extrapolation audit;
modifying notice contents ; prohibiting assessment of
certain fines under certain circumstances; expanding
certain claim limits; es tablishing requirements for
preliminary audit findings reports; requiring
provision of certain final audit results within a
certain time period; updating statutory reference;
requiring certain notification to Attorney General in
certain circumstances; expanding requirement for
initiation of certain audit; lengthening time period
for certain preliminary report; allowing certain
extension request; shortening certain time period for
certain final report; establishing requirements for
audit findings report; mod ifying definition; defining
terms; requiring certain tolling in certain declared
disaster; providing certain exceptions; amending 59
O.S. 2021, Sections 357 and 358, as amended b y
Sections 4 and 5, Chapter 332, O.S.L. 2024 (59 O.S.
Supp. 2024, Sections 357 and 358), which relate to
definitions and pharmacy benefits management
licensure; defining terms; updating statutory
references; requiring certain time period of tolling
in certain declared disaster; establishing certain
filing period after lifting of dis aster declaration;
prohibiting certain denials; and declaring an
emergency.
Req. No. 698 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 59 O.S. 2021, Section 356.1, as
amended by Section 1, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
Section 356.1), is amended to read as follows:
Section 356.1. A. For purposes of the Pharmacy Audit Integrity
Act, “pharmacy benefits manager ”:
1. “Pharmacy benefits manager” or “PBM” shall have the same
meaning as in Section 6960 of Title 36 of the Oklahoma Statutes ;
2. “Audit” means any review, inspection, or analysis conducted
by a PBM or its representative of a pharmacy ’s records, practices,
or compliance with contractual obligations; and
3. “Disaster declaration” and “declared disaster” means a
declaration issued by the Governor of this state or the President of
the United States for an event that qualifies as a disaster
including, but not limited to, floods, tornadoes, earthquakes,
wildfires, terrorist attacks, o r other catastrophic events .
B. The purpose of the Pharmacy Audit Integrity Act is to
establish minimum and uniform standards and criteria for the audit
of pharmacy records by o r on behalf of certain entities.
C. The Pharmacy Audit Integrity Act shall apply to any audit of
the records of a pharmacy conducted by a managed care company,
nonprofit hospital, medical service organization, insurance company,
third-party payor, pharmac y benefits manager, a health program
Req. No. 698 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
administered by a department of this stat e, or any entity that
represents these companies, groups, or departments.
D. The Attorney General may promulgate rules to implement the
provisions of the Pharmacy Audit Integrit y Act.
SECTION 2. AMENDATORY 59 O.S. 2021, Section 356.2, as
amended by Section 2, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
Section 356.2), is amended to read as follows:
Section 356.2. A. The entity conducting an audit of a pharmacy
shall:
1. Identify and specifically describe the audit and appeal
procedures in the pharmacy contract. Prescription claim
documentation and record -keeping requirements shall not exceed the
requirements set forth by the Oklahoma Pharmacy Act or other
applicable state or federal laws or regulations;
2. Give the pharmacy written notice by certified letter to the
pharmacy and the pharmacy ’s contracting agent, including
identification of specific prescription numbers and, fill dates,
drug name, and National Drug Code (NDC) number to be audited, at
least fourteen (14) calenda r days prior to conducting the audit,
including, but not limited to, an on -site audit, a desk audit, or a
wholesale purchase audit, request for documentation related to the
dispensing of a prescription drug or any reimbursed activity by a
pharmacy provider; provided, however, that wholesale purchase audits
shall require a minimum of thirty (30) calendar days ’ written
Req. No. 698 Page 4 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
notice. For an on-site audit, the audit date shall be the date the
on-site audit occurs. For all other audit types, the audit date
shall be the date the pharmacy provides the documentation requested
in the audit notice. The pharmacy shall have the opportunity to
reschedule the audit no more than seven (7) calendar d ays from the
date designated on the original audit notification;
3. Not interfere with the delivery of pharmacist services to a
patient and shall utilize every reasonable effort to minimize
inconvenience and disruption to pharmacy operations during the au dit
process;
4. Conduct any audit involving clinical or professional
judgment by means of or in consultation with a licensed pharmacist;
5. Not consider as fraud any clerical or record -keeping error,
such as a typographical error, scrivener ’s error or computer error,
including, but not limited to, a miscalculated day supply,
incorrectly billed prescription written date or prescription origin
code, and such errors shall not be subject to recoupment. The
pharmacy shall have the right to submit amended clai ms
electronically to correct clerical or record -keeping errors in lieu
of recoupment. To the extent that an audit results in the
identification of any clerical or record -keeping errors such as
typographical errors, scrivener ’s errors or computer errors in a
required document or record, the pharmacy shall not be subject to
recoupment of funds by the pharmacy benefits manager unless the
Req. No. 698 Page 5 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
pharmacy benefits manager can provide proof of intent to commit
fraud. A person shall not be subject to criminal penalties for
errors provided for in this paragraph without proof of intent to
commit fraud;
6. Permit a pharmacy to use the records of a hospital,
physician, or other authorized practitioner of the healing arts for
drugs or medicinal supplies written or transmitt ed by any means of
communication for purposes of validating the pharmacy record with
respect to orders or refills of a legend or narcotic drug;
7. Not include the dispensing fee amount or the actual invoice
cost of the prescription dispensed in a finding of an audit
recoupment unless a prescription was not actually dispensed or a
physician denied authorization of a dispensing order;
8. Audit each pharmacy under identical standards, regularity
and parameters as other similarly situated pharmacies and all
pharmacies owned or managed by the pharmacy benefits manager
conducting or having conducted the audit;
9. Not exceed one (1) year from the date the claim was
submitted to or adjudicated by a managed care company, nonprofit
hospital or medical service organ ization, insurance company, third -
party payor, pharmacy benefits manager, a he alth program
administered by a department of this state, or any entity that
represents the companies, groups, or departments for the period
covered by an audit;
Req. No. 698 Page 6 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
10. Not schedule or initiate an audit during the first seven
(7) calendar days of any month unless otherwise consented to by the
pharmacy;
11. Disclose to any plan sponsor whose claims were included in
the audit any money recouped in the audit;
12. Not require pharmacis ts to break open packaging labeled
“for single-patient-use only”. Packaging labeled “for single-
patient-use only” shall be deemed to be the smallest package size
available; and
13. Upon recoupment of funds from a pharmacy, refund first to
the patient the portion of the recovered funds that were originally
paid by the patient, provided such funds were part of the
recoupment; and
14. Not assess a fine, penalty, or any other financial
requirement on the pharmacy or pharmacist for any prescription
audited unless there is a valid recoupment under the Pharmacy Audit
Integrity Act.
B. 1. Any entity that conducts wholesale purchase review
during an audit of a pharmacist or pharmacy shall not require the
pharmacist or pharmacy to provide a full dispensing report .
Wholesaler invoice reviews shall be limited to verification of
purchase inventory specific to the pharmacy claims paid by the
health benefits plan or pharmacy benefits manager conducting the
audit.
Req. No. 698 Page 7 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
2. Any entity conducting an audit shall not identify o r label a
prescription claim as an audit discrepancy when:
a. the National Drug Code for the dispensed drug is in a
quantity that is a subunit or multiple of the drug
purchased by the pharmacist or pharmacy as supported
by a wholesale invoice,
b. the pharmacist or pharmacy dispensed the correct
quantity of the drug according to the prescription,
and
c. the drug dispensed by the pharmacist or pharmacy
shares all but the last two digits of the National
Drug Code of the drug reflected on the supplier
invoice.
3. An entity conducting an audit shall accept as evidence,
subject to validation, to support the validity of a pharmacy claim
related to a dispensed drug:
a. redacted copies of supplier invoices in the
pharmacist’s or pharmacy’s possession, or
b. invoices and any supporting documents from any
supplier as authorized by federal or state law to
transfer ownership of the drug acquired by the
pharmacist or pharmacy.
4. An entity conducting an audit shall provide, no later than
five (5) calendar days after the date of a request by the pharmacist
Req. No. 698 Page 8 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
or pharmacy, all supporting documents the pharmacist’s or pharmacy’s
purchase suppliers provided to the health benefits plan issuer or
pharmacy benefits manager.
C. A pharmacy shall be allowed to provide the pharmacy ’s
computerized patterned medical records or the records of a hospital,
physician, or other authorized practitioner of the healing arts for
drugs or medicinal supplies written or transmitted by any means of
communication for purposes of supporting the pharmac y record with
respect to orders or refills of a legend or narcotic drug.
D. The entity conducting the audit shall not audit more than
fifty prescriptions, with specific date of service, per calendar
year. The PBM or its agent shall not exceed an annual l imit of one
hundred prescription claims with a specific prescription number and
date of fill per calendar year. The annual limit to the number of
prescription claims audited shall be inclusive of all audits by a
PBM or its agent, including any prescriptio n-related documentation
requests from the health insurer, pharmacy benefits ma nager or any
third-party company conducting audits on behalf of any health
insurer or pharmacy benefits manager during a calendar year.
E. If paper copies of records are request ed by the entity
conducting the audit, the entity shall pay twenty -five cents ($0.25)
per page to cover the costs incurred by the pharmacy. The entity
conducting the audit shall provide the pharmacy with accurate
Req. No. 698 Page 9 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
instructions, including any required form for obtaining
reimbursement for the copied records.
F. The entity conducting the audit shall:
1. Deliver a preliminary audit findings report to the pharmacy
and the pharmacy’s contracting agent within forty -five (45) calendar
days of conducting the audit ;
2. Allow the pharmacy at least ninety (90) calendar days
following receipt of the preliminary audit findings report in which
to produce documentation to address any discrepancy found during the
audit; provided, however, a pharmacy may request an extensi on, not
to exceed an additional forty -five (45) calendar days;
3. Deliver a final audit findings report to the pharmacy and
the pharmacy’s contracting agent signed by the auditor within ten
(10) calendar days after receipt of additional documentation
provided by the pharmacy, as provided for in Section 356.3 of this
title;
4. Allow the pharmacy to reverse and resubmit claims
electronically within thirty (30) calendar days of receipt of the
final audit report in lieu of the auditing entity recouping
discrepant claim amounts from the pharmacy;
5. Not recoup any disputed funds until after final disposition
of the audit findings, including the appeals process as provided for
in Section 356.3 of this title; and
6. Not accrue interest during the audit and appe al period;
Req. No. 698 Page 10 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
7. Ensure that each preliminary audit findings report required
by this section includes:
a. specific prescription numbers, fill dates, drug name s,
and NDC numbers, and
b. the date of receipt of documents from the pharmacy,
the pharmacy’s contracting agent, or any other source
associated with the audit .
G. Each entity conducting an audit shall provide a copy of the
final audit results, and a final audit report upon request, after
completion of any review process to the plan sponsor
In addition to the requirements for a preliminary audit findings
report in this paragraph, the final audit findings report shall
include any additional documentation that was submitted to the
auditing entity;
8. Provide the plan sponsor a copy of the final audit resul ts
within thirty (30) calendar days of the final disposition of the
audit; and
9. At the request of the plan sponsor , provide a copy of the
final audit report within thirty (30) calendar days of the request .
H. G. 1. The full amount of any recoupment on an audit shall
be refunded to the plan sponsor. Except as provided for in
paragraph 2 of this subsection, a charge or assessment for an audit
shall not be based, directly or indirectly, on amounts recouped.
Req. No. 698 Page 11 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
2. This subsection does not prevent the entity conducting the
audit from charging or assessing the responsible party, direct ly or
indirectly, based on amounts recouped if both of the following
conditions are met:
a. the plan sponsor and the entity conducting the audit
have a contract that explicitly s tates the percentage
charge or assessment to the plan sponsor, and
b. a commission to an agent or employee of the entity
conducting the audit is not based, directly or
indirectly, on amounts recouped.
I. H. Unless superseded by state or federal law, audit ors shall
only have access to previous audit reports on a particular pharmacy
conducted by the auditing entity for the same pharmacy benefits
manager, health plan or insurer. An auditing vendor contracting
with multiple pharmacy benefits managers or healt h insurance plans
shall not use audit reports or other information gained from an
audit on a pharmacy to conduct another audit for a different
pharmacy benefits manager or health insurance plan.
J. Sections A through I
I. Paragraph 2 of subsection A of this section through
subsection D of this section, and paragraph 1 through par agraph 7 of
subsection F of this section shall not apply to any audit initiated
based on or that involves suspicion of fraud, willful
misrepresentation, or abuse.
Req. No. 698 Page 12 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
K. J. If the Attorney General, after notice and opportunity for
hearing, finds that the entity conducting the audit failed to follow
any of the requirements pursuant to the Pharmacy Audit Integrity
Act, the audit shall be considered null and void. Any monies
recouped from a null and void audit shall be returned to the
affected pharmacy within fo urteen (14) calendar days. Any violation
of this section by a pharmacy benefits manager or auditing entity
shall be deemed a violation of the Pharmacy Audit Integrity Act.
SECTION 3. AMENDATORY 59 O.S. 2021, Section 356.3, as
amended by Section 3, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
Section 356.3), is amended to read as follows:
Section 356.3. A. Each entity conducting an audit shall
establish a written appeals process under which a pharmacy may
appeal an unfavorable p reliminary audit report and/or final audit
report to the entity.
B. Following an appeal, if the entity finds that an unfavorable
audit report or any portion thereof is unsubstan tiated, the entity
shall dismiss the audit report or the unsubstantiated portion of the
audit report without any further action.
C. Any final audit report, following the final audit appeal
period, with a finding of fraud or willful misrepresentation shall
be referred to the district attorney having proper jurisdiction or
the Attorney General for prosecution upon completion of the appeals
process. If a finding of fraud, willful misrepresentation, or abuse
Req. No. 698 Page 13 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
is referred to a district attorney under this subse ction, the
auditing entity shall notify the Attorney General to whom the
referral was made and the date the referral was made.
D. For any audit initiated based on or that involves suspicion
of fraud, willful misrepresentation, or abuse, the auditing entit y
shall provide, in writing, at the time of the audit, a clear and
conspicuous declaration to the pharmacy being audited that the audit
is being conducted under suspicion of fraud, willful
misrepresentation, or abuse and a statement of facts that supports
the reasonable suspicion.
E. Any entity conducting an audit that is based on or involves
suspicion of fraud, willful misrepresentation, or abuse shall
provide to the Office of the Attorney General:
1. Notice at least two (2) calendar days prior to beginn ing
performance of an audit pursuant to this section;
2. A preliminary report within thirty (30) ninety (90) calendar
days of performing notification of the audit to the pharmacy and the
pharmacy’s contracting agent pursuant to this section . The auditing
entity may request an extension from the Attorney General, not to
exceed an additional thirty (30) calendar days ; and
3. A final report within thirty (30) ten (10) calendar days
following the closure of the final appeal period for an audit
performed pursuant to this section. The auditing entity may request
Req. No. 698 Page 14 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
an extension from the A ttorney General, not to exceed an additional
ten (10) calendar days.
F. 1. The preliminary audit findings report required by
subsection E of this section shall include:
a. specific prescription numbers, fill dates, drug name s,
and National Drug Code ( NDC) numbers which were part
of the audit, and
b. the dates when documents were received by the auditing
entity from the pharmacy, the pharmacy ’s contracting
agent, or any other sou rce associated with the audit.
2. In addition to the requirements for a preli minary audit
findings report pursuant to this subsection, the final audit
findings report shall include any additional documentation that was
submitted to the auditing entity.
G. The Attorney General, authorized employees, and examiners
shall have access to any pharmacy benefits manager ’s files and
records that may relate to an audit that is based on or involves
suspicion of fraud, willful misrepresentation, or abuse.
G. H. The Attorney General may levy a civil or administrative
fine of not less than One Hundred Dollars ($100.00) and not greater
than Ten Thousand Dollars ($10,000.00) for each violation of this
section and assess any other penalty or remedy authorized by law.
SECTION 4. AMENDATORY 59 O.S. 2021, Section 356.4, is
amended to read as follows:
Req. No. 698 Page 15 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Section 356.4. A. For the purposes of the Pharmacy Audit
Integrity Act, “extrapolation audit” means an audit of a sample of
prescription drug benefit claims submitted by a pharmacy to the
entity conducting the audit that is then used to estimate audit
results for a larger batch or group of claims not reviewed by the
auditor, including refills not listed in the written notification in
accordance with paragraph 2 of subsection A of Section 356 .2 of this
title.
B. The entity conducting the audit shall not use the accounting
practice of extrapolation in calculating recoupments or penalties
for audits.
SECTION 5. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 356.6 of Title 59, unless there
is created a duplication in numbering, reads as follows:
A. Notwithstanding any other provision of law, the ability of a
pharmacy benefits manager (PBM) to initiate, continue, or conclude
an audit of a pharmacy shall be tolled for the duration of a
declared disaster and for an additional period of thirty (30)
calendar days following the termination of a declared disaster.
This shall apply only to the pharmacies locat ed within the
geographical boundaries of the county or counties affected by th e
declared disaster.
Req. No. 698 Page 16 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. The provisions of this section shall apply to all PBMs
operating with within this state, and to all audits conducted
pursuant to contracts between PBMs a nd pharmacies.
C. This section shall not apply to:
1. Audits conducted for suspected fraudulent activity if
documented evidence of such activity exists; or
2. Audits required to comply with federal or state law
unrelated to the contractual relationship between a PBM and a
pharmacy.
D. Nothing in this section shall be construed t o prohibit a
pharmacy from voluntarily agreeing to continue or complete an audit
during the tolling period, provided such agreement is documented in
writing and signed by both pa rties.
SECTION 6. AMENDATORY 59 O.S. 2021, Section 357, as
amended by Section 4, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
Section 357), is amended to read as follows:
Section 357. A. As used in Sections 357 through 360 of this
title and Section 8 of this act:
1. “Covered entity” means a nonprofit ho spital or medical
service organization, for -profit hospital or medical service
organization, insurer, health benefit plan, health maintenance
organization, health program adminis tered by the state in the
capacity of providing health coverage, or an employer, labor union,
or other group of persons that provides health coverage to persons
Req. No. 698 Page 17 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
in this state. This term does not include a health benefit plan
that provides coverage only fo r accidental injury, specified
disease, hospital indemnity, disability income, or other limited
benefit health insurance policies and contracts that do not include
prescription drug coverage;
2. “Covered individual” means a member, participant, enrollee,
contract holder or policy holder or beneficiary of a covered entity
who is provided health coverage by the covered entity. A covered
individual includes any dependent or other person provided health
coverage through a policy, contract or plan for a covere d
individual;
3. “Department” means the Insurance Department;
4. “Maximum allowable cost”, “MAC”, or “MAC list” means the
list of drug products delineating the maximum per -unit reimbursement
for multiple-source prescription drugs, medical product, or dev ice;
5. “Multisource drug product reimbursement ” (reimbursement)
means the total amount paid to a pharmacy inclusive of any reduction
in payment to the pharmacy, excluding prescription dispense fees;
6. “Office” means the Office of the Attorney General;
7. “Pharmacy benefits management ” means a service provided to
covered entities to facilitate the provision of prescription drug
benefits to covered individuals within the state, including
negotiating pricing and other terms with drug manufacturers and
Req. No. 698 Page 18 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
providers. Pharmacy benefits management may include any or all of
the following services:
a. claims processing, retail network management and
payment of claims to pharmacies for prescription drugs
dispensed to covered individuals,
b. clinical formulary devel opment and management
services, or
c. rebate contracting and administration;
8. “Pharmacy benefits manager ” or “PBM” means a person,
business, or other entity that performs pharmacy benefits
management. The term shall include a person or entity acting on
behalf of a PBM in a contractual or employment relationship in the
performance of pharmacy benefits management for a managed care
company, nonprofit hospital, medical service organization, insurance
company, third-party payor, or a health program administ ered by an
agency or department of this state;
9. “Plan sponsor” means the employers, insurance companies,
unions and health maintenance organizations or any other entity
responsible for establishing, maintaining, or administering a health
benefit plan on behalf of covered individuals; and
10. “Provider” means a pharmacy licensed by the State Board of
Pharmacy, or an agent or representative of a pharmacy, including,
but not limited to, the pharmacy ’s contracting agent, which
dispenses prescription drugs o r devices to covered individuals.
Req. No. 698 Page 19 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. Nothing in the definition of pharmacy be nefits management or
pharmacy benefits manager in the Patient ’s Right to Pharmacy Choice
Act, Pharmacy Audit Integrity Act, or Sections 357 through 360 of
this title and Section 8 of this act shall deem an employer a
“pharmacy benefits manager ” of its own self-funded health benefit
plan, except, to the extent permitted by applicable law, where the
employer, without the utilization of a third party and unrelated to
the employer’s own pharmacy:
a. negotiates
1. Negotiates directly with drug manufacturers ,;
b. processes
2. Processes claims on behalf of its members ,; or
c. manages
3. Manages its own retail network of pharmacies.
SECTION 7. AMENDATORY 59 O.S . 2021, Section 358, as
amended by Section 5, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
Section 358), is amended to read as follows:
Section 358. A. In order to provide pharmacy benefits
management or any of the services included under the definition of
pharmacy benefits management in this state, a pharmacy benefits
manager or any entity acting as one in a contractual or employment
relationship for a covered entity shall first obtain a license from
the Insurance Department, and the Department may char ge a fee for
such licensure.
Req. No. 698 Page 20 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. The Department shall establish, by regulation, licensure
procedures, required disclosures for pharmacy benefits managers
(PBMs) and other rules as may be necessary for carrying out and
enforcing the provisions of this title . The licensure procedures
shall, at a minimum, include the completion of an application form
that shall include the name and address of an agent for service of
process, the payment of a requisite fee, and evidence of the
procurement of a surety bond.
C. The Department or the Office of the Attorney General may
subpoena witnesses and information. Its compliance officers may
take and copy records for investigative use and prosecutions.
Nothing in this subsection shall limit the Office of the Attorney
General from using its investigative demand authority to investigate
and prosecute violations of the law.
D. The Department may suspend, revoke or refuse to issue or
renew a license for noncompliance with any of the provisions hereby
established or with the r ules promulgated by the Department; for
conduct likely to mislead, deceive or defraud the public or the
Department; for unfair or deceptive business practices or for
nonpayment of an application or renewal fee or fine. The Department
may also levy adminis trative fines for each count of which a PBM has
been convicted in a Department hearing.
E. 1. The Office of the Attorney General , after notice and
opportunity for hearing, may instruct the Insurance Commissioner
Req. No. 698 Page 21 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
that the PBM’s license be censured, suspended, or revoked for
conduct likely to mislead, deceive, or defraud the public or the
State of Oklahoma; or for unfair or deceptive business practices, or
for any violation of the Patient’s Right to Pharmacy Choice Act, the
Pharmacy Audit Integrity Act, or Sections 357 through 360 of this
title. The Office of the Attorney General ma y also levy
administrative fines for each count of which a PBM has been
convicted following a hearing before the Attorney General. If the
Attorney General makes such instruction , the Commissioner shall
enforce the instructed action within thirty (30) calendar days.
2. In addition to or in lieu of any censure, suspension, or
revocation of a license by the Commissioner, the Attorney General
may levy a civil or administrative fine of not less than One Hundred
Dollars ($100.00) and not greater than Ten Thousa nd Dollars
($10,000.00) for each violation of this subsection and/or assess any
other penalty or remedy authorized by this section. For purposes of
this section, each day a PBM fails to comply with an investigation
or inquiry may be considered a separate violation.
F. The Attorney General may promulgate rules to implement the
provisions of Sections 357 through 360 of this title and Section 8
of this act.
SECTION 8. NEW LAW A new section of law to be codified
in the Oklahoma Statute s as Section 360.1 of Title 59, unless there
is created a duplication in numbering, reads as follows:
Req. No. 698 Page 22 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
A. If a disaster declaration is issued for a county in this
state, the time period for a provider, a provider ’s representative,
or a pharmacy service administrative organization to file a below -
cost reimbursement appeal pursuant to Section 360 of Title 59 of the
Oklahoma Statutes shall be tolled for the duration of the disaster
declaration.
B. Upon the expiration of the disaster declaration, the tolling
of the filing period for below -cost reimbursement appeals shall
continue for an additional thirty (30) calendar days. Afterward,
the time period for filing a below -cost reimbursement appeal, as
otherwise provided under state law, shall resume.
C. The tolling provisions of this section shall apply only to
continuing counties included in the declared disaster area and to
below-cost reimbursement appeals arising from claims impacted during
the time period of the declared disaster.
D. A pharmacy benefits mana ger (PBM) shall not deny a below -
cost reimbursement appeal on timeliness if such appeal is filed
during the tolled period provided in this section.
SECTION 9. It being immediately necessary for the preservation
of the public peace, health or safety, an emergency is hereby
declared to exist, by reason whereof this act shall take effect and
be in full force from and after its passage and approval.
60-1-698 CAD 1/16/2025 2:13:26 PM